Insmed Inc
NASDAQ:INSM

Watchlist Manager
Insmed Inc Logo
Insmed Inc
NASDAQ:INSM
Watchlist
Price: 66.02 USD -3.63% Market Closed
Market Cap: 12B USD
Section:
Wall Street Price Targets
Wall Street Price Targets
Revenue Forecast
Operating Income Forecast
Net Income Forecast
See Also
Price Target
Average
+11%
Revenue
Forecast
-35%
Net Income
Forecast
-24%

Wall Street
Price Targets

INSM Price Targets Summary
Insmed Inc

Wall Street analysts forecast INSM stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for INSM is 97.54 USD with a low forecast of 70.7 USD and a high forecast of 115.5 USD.

INSM Lowest Forecast
Wall Street Target
70.7 USD
7% Upside
INSM Average Forecast
Wall Street Target
97.54 USD
48% Upside
INSM Highest Forecast
Wall Street Target
115.5 USD
75% Upside
Lowest
Price Target
70.7 USD
7% Upside
Average
Price Target
97.54 USD
48% Upside
Highest
Price Target
115.5 USD
75% Upside
Insmed Inc Competitors:
Price Targets
ITOS
Iteos Therapeutics Inc
210% Upside
C
COYA
Coya Therapeutics Inc
190% Upside
TSVT
2Seventy Bio Inc
2% Upside
PRQR
ProQR Therapeutics NV
508% Upside
ITOS
Iteos Therapeutics Inc
210% Upside
C
COYA
Coya Therapeutics Inc
190% Upside
TSVT
2Seventy Bio Inc
2% Upside
PRQR
ProQR Therapeutics NV
508% Upside
002252
Shanghai RAAS Blood Products Co Ltd
2% Upside
4597
Solasia Pharma KK
78% Upside
S
SANA
Sana Biotechnology Inc
394% Upside
DVAX
Dynavax Technologies Corp
147% Upside

Revenue
Forecast

Revenue Estimate
Insmed Inc

The compound annual growth rate of Insmed Inc's revenue for the next 3 years is 74%.

N/A
Past Growth
74%
Estimated Growth
Estimates Accuracy
-1%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Insmed Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
0%
Average Beat
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Insmed Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-40%
Average Miss
What are analyst estimates?

See Also

Summary
INSM intrinsic value, competitors valuation, and company profile.
DCF Valuation
INSM stock valuation using Discount Cash Flow valuation method.
Relative Valuation
INSM stock valuation using valuation multiples.
Wall Street Estimates
INSM price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
INSM stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is INSM's stock price target?
Price Target
97.54 USD

According to Wall Street analysts, the average 1-year price target for INSM is 97.54 USD with a low forecast of 70.7 USD and a high forecast of 115.5 USD.

What is Insmed Inc's Revenue forecast?
Projected CAGR
74%

The compound annual growth rate of Insmed Inc's revenue for the next 3 years is 74%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 256,300+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.